Articles with public access mandates - Marion EhrichLearn more
Not available anywhere: 2
Potent induction of total cellular and mitochondrial antioxidants and phase 2 enzymes by cruciferous sulforaphane in rat aortic smooth muscle cells: cytoprotection against …
H Zhu, Z Jia, JS Strobl, M Ehrich, HP Misra, Y Li
Cardiovascular toxicology 8, 115-125, 2008
Mandates: US National Institutes of Health
Effects of chlorpyrifos on transient receptor potential channels
W Li, M Ehrich
Toxicology Letters 358, 100-104, 2022
Mandates: US National Institutes of Health
Available somewhere: 22
Cerium oxide nanoparticles in neuroprotection and considerations for efficacy and safety
BA Rzigalinski, CS Carfagna, M Ehrich
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 9 (4), e1444, 2017
Mandates: US National Institutes of Health
Engineering the lipid layer of lipid–PLGA hybrid nanoparticles for enhanced in vitro cellular uptake and improved stability
Y Hu, R Hoerle, M Ehrich, C Zhang
Acta biomaterialia 28, 149-159, 2015
Mandates: US National Institutes of Health
Fullerene antioxidants decrease organophosphate-induced acetylcholinesterase inhibition in vitro
M Ehrich, R Van Tassell, Y Li, Z Zhou, CL Kepley
Toxicology in Vitro 25 (1), 301-307, 2011
Mandates: US National Institutes of Health
A novel class of compounds with cutaneous wound healing properties
Z Zhou, S Joslin, A Dellinger, M Ehrich, B Brooks, Q Ren, U Rodeck, ...
Journal of biomedical nanotechnology 6 (5), 605-611, 2010
Mandates: US National Institutes of Health
In vitro performance of lipid-PLGA hybrid nanoparticles as an antigen delivery system: lipid composition matters
Y Hu, M Ehrich, K Fuhrman, C Zhang
Nanoscale research letters 9, 1-10, 2014
Mandates: US National Institutes of Health
Rational incorporation of molecular adjuvants into a hybrid nanoparticle-based nicotine vaccine for immunotherapy against nicotine addiction
Z Zhao, B Harris, Y Hu, T Harmon, PR Pentel, M Ehrich, C Zhang
Biomaterials 155, 165-175, 2018
Mandates: US National Institutes of Health
The next-generation nicotine vaccine: a novel and potent hybrid nanoparticle-based nicotine vaccine
Y Hu, D Smith, E Frazier, R Hoerle, M Ehrich, C Zhang
Biomaterials 106, 228-239, 2016
Mandates: US National Institutes of Health
Negatively charged carbon nanohorn supported cationic liposome nanoparticles: a novel delivery vehicle for anti-nicotine vaccine
H Zheng, Y Hu, W Huang, S De Villiers, P Pentel, J Zhang, H Dorn, ...
Journal of biomedical nanotechnology 11 (12), 2197-2210, 2015
Mandates: US National Institutes of Health
In vitro controlled release of antigen in dendritic cells using pH-sensitive liposome-polymeric hybrid nanoparticles
Y Hu, Z Zhao, M Ehrich, K Fuhrman, C Zhang
Polymer 80, 171-179, 2015
Mandates: US National Institutes of Health
Investigating acetaminophen hepatotoxicity in multi-cellular organotypic liver models
SM Orbach, ME Cassin, MF Ehrich, P Rajagopalan
Toxicology in Vitro 42, 10-20, 2017
Mandates: US National Science Foundation
Rationalization of a nanoparticle-based nicotine nanovaccine as an effective next-generation nicotine vaccine: A focus on hapten localization
Z Zhao, Y Hu, T Harmon, P Pentel, M Ehrich, C Zhang
Biomaterials 138, 46-56, 2017
Mandates: US National Institutes of Health
Exploratory studies with BT-11: a proposed orally active therapeutic for Crohn’s disease
P Bissel, K Boes, J Hinckley, BS Jortner, G Magnin-Bissel, SR Werre, ...
International journal of toxicology 35 (5), 521-529, 2016
Mandates: US National Institutes of Health
Paradox of PEGylation in fabricating hybrid nanoparticle-based nicotine vaccines
Y Hu, Z Zhao, T Harmon, PR Pentel, M Ehrich, C Zhang
Biomaterials 182, 72-81, 2018
Mandates: US National Institutes of Health
Exploratory studies with NX-13: oral toxicity and pharmacokinetics in rodents of an orally active, gut-restricted first-in-class therapeutic for IBD that targets NLRX1
A Leber, R Hontecillas, V Zoccoli-Rodriguez, M Ehrich, J Chauhan, ...
Drug and chemical toxicology 45 (1), 209-214, 2022
Mandates: US National Institutes of Health
High-throughput toxicity testing of chemicals and mixtures in organotypic multi-cellular cultures of primary human hepatic cells
SM Orbach, MF Ehrich, P Rajagopalan
Toxicology in Vitro 51, 83-94, 2018
Mandates: US National Science Foundation
Hybrid nanoparticle-based nicotine nanovaccines: Boosting the immunological efficacy by conjugation of potent carrier proteins
Z Zhao, Y Hu, T Harmon, PR Pentel, M Ehrich, C Zhang
Nanomedicine: Nanotechnology, Biology and Medicine 14 (5), 1655-1665, 2018
Mandates: US National Institutes of Health
Alum as an adjuvant for nanoparticle based vaccines: A case study with a hybrid nanoparticle-based nicotine vaccine
Y Hu, D Smith, Z Zhao, T Harmon, PR Pentel, M Ehrich, C Zhang
Nanomedicine: Nanotechnology, Biology and Medicine 20, 102023, 2019
Mandates: US National Institutes of Health
Formulation of nanovaccines toward an extended immunity against nicotine
Y Hu, Z Zhao, M Ehrich, C Zhang
ACS applied materials & interfaces 13 (24), 27972-27982, 2021
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program